"we were fully aware of the fact that our twins would be the first babies in the world to receive this treatment in utero," corinna said..
the obvious reason: their big-spending pharmaceutical advertisers would drop them like hot potatoes... .eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention..